Cocaine-opioid interactions in groups of rats trained to discriminate different doses of cocaine

Psychopharmacology

Volumn 147, Issue 3, 1999, Pages 257-265

  Kantak, Kathleen M ^a   Riberdy, Anne ^a   Spealman, Roger D ^b  

^a BOSTON UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

receptor; receptor; Cocaine; Drug discrimination; Morphine; Training dose; U50,488

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; COCAINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENCY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRAINING;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, OPIOID; ANIMALS; COCAINE; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; NARCOTICS; RATS; RATS, WISTAR;

EID: 0033989567     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051165     Document Type: Article

References (52)

1. Broadbent J, Gaspard TM, Dworkin SI (1995) Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids. Pharmacol Biochem Behav 51:379-385
2. Chesselet MF, Cheramy A, Reisine TD, Glowinski J (1981) Morphine and δ-opioid agonists locally stimulate in vivo dopamine release in cat caudate nucleus. Nature 291:320-322
3. Crawford CA, McDougall SA, Bolanos CA, Hall S, Berger SP (1995) The effects of the kappa agonist, U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharmacology 120:392-399
4. Davis MD, Ball LM (1991) Kappa-opioid agonists depress rat striatal dopamine outflow in vivo and in vitro: an intracerebral microdialysis and nigrostriatal explant study. Soc Neurosci Abstr 17:89
5. Darke S, Hall W (1995) Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 39:231-235
6. DiChiara G, Imperato A (1988a) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080
7. DiChiara G, Imperato A (1988b) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278
8. Dykstra LA, Doty P, Johnson AB, Picker MJ (1992) Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drugs Alcohol Depend 30:227-243
9. Finney DJ (1964) Statistical methods in biological assay, 2nd edn. Hafner, New York
10. Foltin RW, Fischman MW (1992) The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J Pharmacol Exp Ther 261:623-632
11. Foltin RW, Christiansen I, Levin FR, Fischman MW (1995) Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. J Pharmacol Exp Ther 275:38-47
12. Frank B, Galea J (1996) Cocaine trends and other drug trends in New York City, 1986-1994. J Addict Dis 15:1-12
13. Glick SD, Maisonneuve IM, Raucci J, Archer S (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147-152
14. Harrison LM, Kastin AJ, Zadina JE (1998) Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 19:1603-1630
15. Heikkila RE, Orlansky H, Cohen G (1975) Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices. Biochem Pharmacol 24:847-852
16. Hemby SE, Co C, Dworkin SI, Smith JE (1999) Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (speedball) in rats. J Pharmacol Exp Ther 288:274-280
17. Holtzman SG (1990) Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse. (Modern methods in pharmacology, vol 6). Wiley-Liss, New York, pp 193-210
18. Kantak KM, Edwards MA, Spealman RD (1995) Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: Comparison with direct and indirect dopamine agonists. J Pharmacol Exp Ther 274:657-665
19. Kauppila T, Mecke E, Pertovaara A (1992) Enhancement of morphine-induced analgesia and attenuation of morphine-induced side-effects by cocaine in rats. Pharmacol Toxicol 71:173-178
20. Kimmel HL, Holtzman SG (1997) Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat. J Pharmacol Exp Ther 282:734-746
21. Kleven MS, Anthony EW, Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254:13-22
22. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661
23. Koek W, Kleven MS, Colpaert FC (1995) Effects of the NMDA antagonist, dizocilpine, in various drug discriminations: Characterization of intermediate levels of drug lever selection. Behav Pharmacol 6:590-600
24. Lamas X, Negus SS, Gatch MB, Mello NK (1998) Effects of heroin/cocaine combinations in rats trained to discriminate heroin or cocaine from saline. Pharmacol Biochem Behav 60:357-364
25. Leone P, Pocock D, Wise RA (1991) Morphine-dopamine interactions: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav 39:469-472
26. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurol Sci 11:308-314
27. Masukawa Y, Suzuki T, Misawa M (1993) Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology 111:139-143
28. Mello NK, Negus SS, Lukas SE, Mendelson JH, Sholar JW, Drieze J (1995) A primate model of polydrug abuse: cocaine and heroin combinations. J Pharmacol Exp Ther 274:1325-1337
29. Negus SS, Gatch MB, Mello N (1998) Effects of mu opioid agonists alone and in combination with cocaine and d-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology 18:325-338
30. Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA (1990) Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. J Pharmacol Exp Ther 254:13-22
31. Pontieri FE, Tanda G, DiChiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci USA 92:12304-12308
32. Preston KL, Sullivan JT, Strain EC, Bigelow GE (1996) Enhancement of cocaine's abuse liability in methadone maintenance patients. Psychopharmacology 123:15-25
33. Rowlett JK, Spealman RD (1998) Opioid enhancement of the discriminative stimulus effects of cocaine: evidence for involvement of μ and δ opioid receptors. Psychopharmacology 140:217-224
34. Schechter MD (1997a) Discrete verses cumulative dosing in dose-response discrimination studies. Eur J Pharmacol 326:113-118
35. Schechter MD (1997b) Discriminative characteristics of high and low cocaine administration: effect of other psychostimulants. Pharmacol Biochem Behav 56:457-463
36. Shippenberg TS, LeFevour A, Heidbreder Ch (1996) Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J Pharmacol Exp Ther 276:545-554
37. Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734-1740
38. Spanagel R, Herz A, Shippenberg TS (1993) Dopamine release in the mesolimbic system is modulated by opposing endogenous opioid systems. NIDA Res Monogr 132:109
39. Spealman RD (1992) Use of cocaine discriminative techniques for preclinical evaluation of candidate therapeutics for cocaine dependence. NIDA Res Monogr 119:175-179
40. Spealman RD, Bergman J (1992) Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261:607-615
41. Spealman RD, Bergman J (1994) Opioid modulation of the discriminative stimulus effects of cocaine: comparison of μ, κ, and δ agonists in squirrel monkeys discriminating low doses of cocaine. Behav Pharmacol 5:21-31
42. Spealman RD, Bergman J, Madras BK, Melia KF (1991) Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 258:945-953
43. Suzuki T, Mori T, Tsuji M, Misawa M (1995) Interaction between discriminative stimulus effects of cocaine and morphine. Jpn J Pharmacol 67:341-347
44. Suzuki T, Mori T, Tsuji M, Maeda J, Kishimoto Y, Misawa M, Nagase H (1997) Differential effects of μ-, δ- and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Eur J Pharmacol 324:21-29
45. Tallarida RJ, Murray RB (1987) Manual of pharmacologic calculations with computer programs, 2nd edn. Springer, Berlin Heidelberg New York
46. Terry P, Witkin JM, Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270:1041-1048
47. Ukai M, Mori E, Kameyama T (1997) Modulatory effects of morphine, U50488H and 1,3-di(2-tolyl)guanidine on cocaine-like discriminative stimulus in the rat using two-choice discrete-trial avoidance paradigm. Methods Find Exp Clin Pharmacol 19:541-546
48. Walsh SH, Sullivan JT, Preston KL, Garner JE, Bigelow GE (1996) Effects of naltrexone on responses to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther 279:524-538
49. Wenger G, Wright D (1990) Behavioral effects of cocaine and its interaction with d-amphetamine and morphine in rats. Pharmacol Biochem Behav 35:595-600
50. Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM (1988) κ Receptor regulation of dopamine release from the striatum and cortex of rats and guinea pigs. J Pharmacol Exp Ther 246:282-286
51. Witkin JM, Nichols DE, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713
52. Woolfolk DR, Holtzman SG (1997) μ-, δ- and κ-Opioid receptor agonists do not alter the discriminative stimulus effects of cocaine or d-amphetamine in rats. Drug Alcohol Depend 48:209-220